Early management of unstable angina and non-ST-segment elevation myocardial infarction: Summary of NICE guidance

Heart

Volumn 96, Issue 20, 2010, Pages 1662-1668

  Gray, Huon H ^a,b   Henderson, Robert A ^c   De Belder, Mark A ^d   Underwood, S Richard ^e   Camm, A John ^f  

^a National Clinical Guideline Centre   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^c NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^d JAMES COOK UNIVERSITY   (Australia)

^e ROYAL BROMPTON HOSPITAL   (United Kingdom)

^f ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; FONDAPARINUX; HEPARIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN;

AORTA BALLOON; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CORONARY ARTERY BYPASS GRAFT; HEALTH CARE PLANNING; HEART LEFT VENTRICLE FUNCTION; HOSPITAL DISCHARGE; HUMAN; INVASIVE PROCEDURE; LOADING DRUG DOSE; MEDICAL SPECIALIST; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; ELECTROCARDIOGRAPHY; EVIDENCE-BASED MEDICINE; HUMANS; INTRA-AORTIC BALLOON PUMPING; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT;

EID: 78049274845     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.204511     Document Type: Review

References (19)

1. Fox KA, Anderson FAJ, Goodman SG, et al. Time course of events in acute coronary syndromes: implications for clinical practice from the GRACE registry. Nat Clin Pract Cardiovasc Med 2008;9:580-9.
2. Steg PG, FitzGerald G, Fox KA. Risk stratification in non-ST-segment elevation acute coronary syndromes: troponin alone is not enough. Am J Med 2009;122:107-8.
3. Fox KAA, Dabbous OH, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 2006;333:1091-4.
4. Granger CB, Goldberg RJ, Dabbous O, et al. Predictors of hospital mortality in the Global Registry of Acute Coronary Events. Arch Intern Med 2003; 163:2345-53.
5. Gale CP, Manda SOM, Weston CF, et al. Evaluation of risk scores for risk stratification of acute coronary syndromes in the Myocardial Infarction National Audit Project (MINAP) database. Heart 2009;95:221-7.
6. Fox KA, Poole-Wilson P, Clayton TC, et al. 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet 2005;366:914-20.
7. Stone GW, Bertrand ME, Moses JW, et al. Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: The ACUITY Timing Trial. JAMA 2007;297:591-602.
8. Giugliano RP, White JA, Bode C, et al. Early versus delayed, provisional eptifibatide in acute coronary syndromes. N Engl J Med 2009;360:2176-90.
9. The Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 2006;354:1464-76.
10. Fox KAA, Bassand JP, Mehta SR, et al. Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non-ST-segment elevation acute coronary syndromes. Ann Intern Med 2007;147:304-10.
11. LaPointe NMA, Chen AY, Alexander KP, et al. Enoxaparin dosing and associated risk of in-hospital bleeding and death in patients with non ST-segment elevation acute coronary syndromes. Arch Intern Med 2007;167:1539-44.
12. Stone GW, McLaurin BT, Cox DA, et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 2006;355:2203-16.
13. Stone GW, Ware JH, Bertrand ME, et al. Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial. JAMA 2007;298:2497-506.
14. Mehta SR, Granger CB, Boden WE, et al. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med 2009;360:2165-75.
15. Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: the task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology. Eur Heart J 2007;28:1598-660.
16. Moulopoulos SD, Topaz S, Kolff WJ. Diastolic balloon pumping (with carbon dioxide) in the aorta - a mechanical assistance to the failing circulation. Am Heart J 1962;63:669-75.
17. Ludman P. BCIS Audit 2008. http://www.bcis.org.uk/resources/audit/ audit2007.
18. Birkhead JS, Weston C, Lowe D. National Audit of Myocardial Infarction Project (MINAP) Steering Group. Impact of specialty of admitting physician and type of hospital on care and outcome for myocardial infarction in England and Wales during 2004-5: observational study. BMJ 2006;332:1306-11.
19. Roe MT, Chen AY, Mehta RH, et al. Influence of inpatient service specialty on care processes and outcomes for patients with non-st-segment elevation acute coronary syndromes. Circulation 2007;116:1153-61.